Drug Trial Radar · NCT07182864
MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Sep 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
160
Actual
Start
Jan 6, 2022
Primary completion
Sep 8, 2022
Study completion Oct 8, 2022
Sponsor
- Lead sponsor
- Minghui Pharmaceutical (Hangzhou) LtdIndustry
- Sponsor type
- Industry
- First posted
- Sep 19, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a Phase I/II Study of MH004 in Healthy Adult Volunteers, participants with Mild to Moderate Atopic Dermatitis.
Conditions
- Atopic Dermatitis (AD)
Interventions
MH004 0.1% OintmentDrug
MH004 0.1% ointment applied topically to the affected area as a thin film.
MH004 0.3% OintmentDrug
MH004 0.3% ointment applied topically to the affected area as a thin film.
MH004 1.0% OintmentDrug
MH004 1.0% ointment applied topically to the affected area as a thin film.
MH004 3.0% OintmentDrug
MH004 3.0% ointment applied topically to the affected area as a thin film.
Vehicle OintmentDrug
Matching vehicle ointment applied topically to the affected area as a thin film.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase I: Incidence and severity of Treatment-Emergent Adverse Events (Safety and Tolerability)Time frame: 1 year
- Phase II: Mean Percentage Change From Baseline in EASI Score at Week 4 in Participants Treated With MH004 OintmentTime frame: Baseline and week 4.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Huashan Hospital Affiliated to Fudan University
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.